SIGA Technologies, Inc. (NASDAQ:SIGA – Get Rating) was the target of some unusual options trading on Wednesday. Investors bought 1,200 call options on the stock. This is an increase of approximately 1,438% compared to the average volume of 78 call options.
Several analysts recently commented on the company. TheStreet raised SIGA Technologies from a “c+” rating to a “b” rating in a research note on Monday, April 18th. Zacks Investment Research raised SIGA Technologies from a “sell” rating to a “hold” rating in a research note on Friday, May 13th.
Shares of SIGA opened at $7.39 on Thursday. SIGA Technologies has a 12-month low of $5.66 and a 12-month high of $9.82. The firm has a market capitalization of $535.09 million, a PE ratio of 7.95 and a beta of 0.50. The stock’s fifty day simple moving average is $7.12 and its 200-day simple moving average is $7.16.
The firm also recently declared a dividend, which will be paid on Thursday, June 2nd. Shareholders of record on Tuesday, May 17th will be issued a $0.45 dividend. The ex-dividend date of this dividend is Monday, May 16th.
Several large investors have recently bought and sold shares of SIGA. Royal Bank of Canada grew its holdings in shares of SIGA Technologies by 39.4% during the third quarter. Royal Bank of Canada now owns 7,516 shares of the company’s stock worth $56,000 after buying an additional 2,126 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in SIGA Technologies by 378.2% during the third quarter. BNP Paribas Arbitrage SA now owns 8,951 shares of the company’s stock valued at $66,000 after purchasing an additional 7,079 shares during the last quarter. Citigroup Inc. boosted its position in SIGA Technologies by 18.1% during the third quarter. Citigroup Inc. now owns 10,299 shares of the company’s stock valued at $76,000 after purchasing an additional 1,575 shares during the last quarter. Principal Financial Group Inc. acquired a new position in SIGA Technologies during the third quarter valued at approximately $79,000. Finally, Qube Research & Technologies Ltd acquired a new position in SIGA Technologies during the fourth quarter valued at approximately $82,000. Institutional investors and hedge funds own 34.52% of the company’s stock.
About SIGA Technologies (Get Rating)
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats.
- Get a free copy of the StockNews.com research report on SIGA Technologies (SIGA)
- MarketBeat Podcast: Options Trading As Easy As Trading Stocks
- The TJX Companies: It’s Not All Doom And Gloom In Retail
- Simply Good Foods Stock is Simply Looking Good Down Here
- Shoe Carnival’s Q1 Results Are No Joke, Shares Fall 15%
- Analog Devices Is Ready To Scale New Highs Despite Tech Wreck
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.